Clinical Trial Update: Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial update describing biomarker-driven intensified chemo-immunotherapy with early CNS prophylaxis for diffuse large B-cell lymphoma; status is active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Not specified

Snippet

Sponsor: Nordic Lymphoma Group | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: ACTIVE_NOT_RECRUITING